Genpact Limited (G) Holdings Cut by Bank of America Corp DE
Bank of America Corp DE decreased its holdings in shares of Genpact Limited (NYSE:G) by 12.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 292,607 shares of the business services provider’s stock after selling 39,863 shares during the period. Bank of America Corp DE owned approximately 0.15% of Genpact worth $8,466,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in G. Fort L.P. purchased a new stake in shares of Genpact during the 2nd quarter worth approximately $116,000. Contravisory Investment Management Inc. purchased a new stake in shares of Genpact during the 2nd quarter worth approximately $130,000. Nisa Investment Advisors LLC purchased a new stake in shares of Genpact during the 2nd quarter worth approximately $188,000. BNP Paribas Arbitrage SA boosted its stake in shares of Genpact by 224.0% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 7,375 shares of the business services provider’s stock worth $213,000 after acquiring an additional 5,099 shares in the last quarter. Finally, Summit Trail Advisors LLC boosted its stake in shares of Genpact by 74.4% during the 2nd quarter. Summit Trail Advisors LLC now owns 8,000 shares of the business services provider’s stock worth $231,000 after acquiring an additional 3,412 shares in the last quarter. Institutional investors own 88.53% of the company’s stock.
In other Genpact news, Director Carol Lindstrom sold 2,630 shares of the stock in a transaction on Friday, August 17th. The stock was sold at an average price of $30.44, for a total transaction of $80,057.20. Following the transaction, the director now owns 17,141 shares of the company’s stock, valued at approximately $521,772.04. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Heather White sold 1,367 shares of the stock in a transaction on Monday, August 6th. The stock was sold at an average price of $31.00, for a total value of $42,377.00. The disclosure for this sale can be found here. 1.41% of the stock is currently owned by corporate insiders.
G stock opened at $28.76 on Friday. Genpact Limited has a 1 year low of $27.67 and a 1 year high of $34.79. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.52 and a current ratio of 1.52. The company has a market capitalization of $5.52 billion, a P/E ratio of 19.45, a P/E/G ratio of 1.86 and a beta of 0.55.
Genpact (NYSE:G) last posted its earnings results on Tuesday, August 7th. The business services provider reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Genpact had a return on equity of 22.15% and a net margin of 9.44%. The firm had revenue of $728.56 million for the quarter, compared to analyst estimates of $734.51 million. Analysts expect that Genpact Limited will post 1.56 earnings per share for the current year.
Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; over-the counter services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.
Featured Story: Marijuana Stocks Investing Considerations
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.